Iambic Therapeutics, which specialises in applying AI to drug discovery and development, has filed for an IPO on the Nasdaq, shortly after adding AbbVie to its roster of pharma pa ...

An adjuvanted, trivalent influenza vaccine developed by CSL Seqirus and recently approved in the UK, Aujemflu, will be deployed ahead of the 2027/28 flu season under an agreement with the government.

A consumer advocacy group has scrutinised some of the Most Favoured Nation (MFN) pricing deals the Trump administration has ...

Adding ITM will also give Telix a pipeline of follow-up radiopharma candidates, including clinical-stage diagnostics and ...

ADARx Pharmaceuticals, a San Diego-based biotech developing siRNA therapies for various diseases, has announced the terms for ...

The recommendation by the CHMP sets up an EU approval in the coming weeks for Klygefa (gefurulimab), a dual-binding nanobody ...

The FDA has published the design of its expedited Investigational New Drug (IND) pilot, part of a plan to restore US competitiveness in clinical research, and will now accept applications to take part ...

Beacon Therapeutics is preparing to file for approval of its gene therapy for eye disorder X-linked retinitis pigmentosa ...

Around 1,000 patients in England with a form of incurable breast cancer will be able to get access to AstraZeneca and Daiichi Sankyo's life-extending drug, Enhertu, via the NHS from today. Final draft ...

Avalere Health was the most successful agency, winning three Golds, a Silver and the highly contested accolade of PMi Agency ...

Frehemgo (denecimig, also known as Mim8) – which picked up its first world approval in Saudi Arabia a few days ago – has been ...

Facing considerable pressure in its diabetes and obesity franchises, Novo has revealed a plan to launch five or more ...